Skip to main content
Erschienen in: Clinical and Translational Oncology 9/2014

01.09.2014 | Research Article

Intraoperative radiotherapy-containing multidisciplinary management of trunk-wall soft-tissue sarcomas

verfasst von: C. V. Sole, F. A. Calvo, M. Cambeiro, A. Polo, A. Montero, R. Hernanz, C. Gonzalez, M. Cuervo, D. Perez, M. S. Julian, R. Martinez-Monge

Erschienen in: Clinical and Translational Oncology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

A joint analysis of data from centers within the intraoperative radiotherapy (IORT)-Spanish cooperative initiative was performed to investigate the main contributions of IORT to the multidisciplinary treatment of trunk-wall soft-tissue sarcoma (TW-STS).

Materials and methods

Patients with a histologic diagnosis of TW-STS (primary tumor 53 %; locally recurrent 47 %) with absence of distant metastases, undergoing surgery with radical intent and IORT (median dose 12.5 Gy) were considered eligible for participation in this study. In addition, all primary tumors received external-beam radiotherapy (median dose 50 Gy).

Results

From 1986 to 2012, a total of 68 patients were analyzed in the study from three Spanish institutions. With a median follow-up time of 53 months (range 4–316), 5-year local control (LC) was 58 %. Five-year IORT in-field control, disease-free survival (DFS) and overall survival were 70, 45 and 51 %, respectively. On multivariate analysis, only microscopically involved margin (R1) resection status retained significance in relation to LC (HR 3.97, p < 0.001). In regard to IORT in field control, incomplete resection (HR 3.23, p = 0.008) and recurrent disease status (HR 2.52, p = 0.04) retained a significant association in multivariate analysis.

Conclusion

From this joint analysis emerges the fact that margin and disease status influences local and central control, but DFS remains modest, given the high risk of distant metastases. Intensified local treatment needs to be tested in the context of more efficient concurrent, neo-, and adjuvant systemic therapy.
Literatur
1.
Zurück zum Zitat Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003;9:1941–56.PubMed Borden EC, Baker LH, Bell RS, Bramwell V, Demetri GD, Eisenberg BL, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003;9:1941–56.PubMed
2.
Zurück zum Zitat Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996;14:869–77.PubMed Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol. 1996;14:869–77.PubMed
3.
Zurück zum Zitat LeVay J, O’Sullivan B, Catton C, Bell R, Fornasier V, Cummings B, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys. 1993;27:1091–9.PubMedCrossRef LeVay J, O’Sullivan B, Catton C, Bell R, Fornasier V, Cummings B, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys. 1993;27:1091–9.PubMedCrossRef
4.
Zurück zum Zitat Delaney TF, Kepka L, Goldberg SI, Hornicek FJ, Gebhardt MC, Yoon SS, et al. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2007;67:1460–9.PubMedCrossRef Delaney TF, Kepka L, Goldberg SI, Hornicek FJ, Gebhardt MC, Yoon SS, et al. Radiation therapy for control of soft-tissue sarcomas resected with positive margins. Int J Radiat Oncol Biol Phys. 2007;67:1460–9.PubMedCrossRef
5.
Zurück zum Zitat Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530–43.PubMedCrossRef Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003;97:2530–43.PubMedCrossRef
6.
Zurück zum Zitat Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995;221:185–95.PubMedCentralPubMedCrossRef Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995;221:185–95.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Mattavelli D, Miceli R, Radaelli S, Mattavelli F, Cantù G, Barisella M, et al. Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution. Ann Oncol. 2013;24:2181–9. Mattavelli D, Miceli R, Radaelli S, Mattavelli F, Cantù G, Barisella M, et al. Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution. Ann Oncol. 2013;24:2181–9.
8.
Zurück zum Zitat Gutierrez JC, Perez EA, Franceschi D, Moffat FL Jr, Livingstone AS, Koniaris LG. Outcomes for soft-tissue sarcoma in 8,249 cases from a large state cancer registry. J Surg Res. 2007;141:105–14.PubMedCrossRef Gutierrez JC, Perez EA, Franceschi D, Moffat FL Jr, Livingstone AS, Koniaris LG. Outcomes for soft-tissue sarcoma in 8,249 cases from a large state cancer registry. J Surg Res. 2007;141:105–14.PubMedCrossRef
9.
Zurück zum Zitat Greager JA, Patel MK, Briele HA, Walker MJ, Wood DK, Gupta TK. Soft tissue sarcomas of the adult thoracic wall. Cancer. 1987;59:370–3.PubMedCrossRef Greager JA, Patel MK, Briele HA, Walker MJ, Wood DK, Gupta TK. Soft tissue sarcomas of the adult thoracic wall. Cancer. 1987;59:370–3.PubMedCrossRef
10.
Zurück zum Zitat Gordon MS, Hajdu SI, Bains MS, Burt ME. Soft tissue sarcomas of the chest wall. Results of surgical resection. J Thorac Cardiovasc Surg. 1991;101:843–54.PubMed Gordon MS, Hajdu SI, Bains MS, Burt ME. Soft tissue sarcomas of the chest wall. Results of surgical resection. J Thorac Cardiovasc Surg. 1991;101:843–54.PubMed
11.
Zurück zum Zitat Gross JL, Younes RN, Haddad FJ, Deheinzelin D, Pinto CA, Costa ML. Soft-tissue sarcomas of the chest wall: prognostic factors. Chest. 2005;127:902–8.PubMedCrossRef Gross JL, Younes RN, Haddad FJ, Deheinzelin D, Pinto CA, Costa ML. Soft-tissue sarcomas of the chest wall: prognostic factors. Chest. 2005;127:902–8.PubMedCrossRef
12.
Zurück zum Zitat Duranti L, Gronchi A, Stacchiotti S, Fiore M, Casali PG, Collini P, et al. Localised thoracic sarcomas: outcome improvement over time at a single institution. Eur J Cancer. 2013;49:2689–97. Duranti L, Gronchi A, Stacchiotti S, Fiore M, Casali PG, Collini P, et al. Localised thoracic sarcomas: outcome improvement over time at a single institution. Eur J Cancer. 2013;49:2689–97.
13.
Zurück zum Zitat Salas S, Bui B, Stoeckle E, Terrier P, Ranchere-Vince D, Collin F, et al. Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. Ann Oncol. 2009;20:1127–35.PubMedCrossRef Salas S, Bui B, Stoeckle E, Terrier P, Ranchere-Vince D, Collin F, et al. Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. Ann Oncol. 2009;20:1127–35.PubMedCrossRef
14.
Zurück zum Zitat Petersen IA, Krempien R, Beauchamp C. Extremity and trunk soft-tissue sarcomas. In: Gunderson LL, Willet CG, Calvo FA, Harrison LB, eds. Intraoperative irradiation techniques and results. Current clinical oncology, 2nd ed. New York, Heidelberg: Humana Press, Springer; 2011. p. 387–405. Petersen IA, Krempien R, Beauchamp C. Extremity and trunk soft-tissue sarcomas. In: Gunderson LL, Willet CG, Calvo FA, Harrison LB, eds. Intraoperative irradiation techniques and results. Current clinical oncology, 2nd ed. New York, Heidelberg: Humana Press, Springer; 2011. p. 387–405.
15.
Zurück zum Zitat Pascau J, Santos Miranda JA, Calvo FA, Bouché A, Morillo V, González-San Segundo C, et al. An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists. Int J Radiat Oncol Biol Phys. 2012;83:287–95. Pascau J, Santos Miranda JA, Calvo FA, Bouché A, Morillo V, González-San Segundo C, et al. An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists. Int J Radiat Oncol Biol Phys. 2012;83:287–95.
16.
Zurück zum Zitat Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.PubMedCrossRef Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.PubMedCrossRef
17.
Zurück zum Zitat Call JA, Stafford SL, Petersen IA, Haddock MG. Use of intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: analysis of disease outcomes and toxicity. Am J Clin Oncol. 2012;37:81–5. Call JA, Stafford SL, Petersen IA, Haddock MG. Use of intraoperative radiotherapy for upper-extremity soft-tissue sarcomas: analysis of disease outcomes and toxicity. Am J Clin Oncol. 2012;37:81–5.
18.
Zurück zum Zitat Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.PubMedCrossRef Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113:573–81.PubMedCrossRef
19.
Zurück zum Zitat Rimner A, Brennan MF, Zhang Z, Singer S, Alektiar KM. Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh. Cancer. 2009;115:149–57.PubMedCrossRef Rimner A, Brennan MF, Zhang Z, Singer S, Alektiar KM. Influence of compartmental involvement on the patterns of morbidity in soft tissue sarcoma of the thigh. Cancer. 2009;115:149–57.PubMedCrossRef
20.
Zurück zum Zitat Calvo FA, Sole CV, Cambeiro M, Montero A, Polo A, Gonzalez C, et al. Prognostic value of external beam radiation therapy for locally recurrent soft tissue sarcoma: a multicentric long-term outcome analysis. Int J Radiat Oncol Biol Phys. 2014;88:143–50.PubMedCrossRef Calvo FA, Sole CV, Cambeiro M, Montero A, Polo A, Gonzalez C, et al. Prognostic value of external beam radiation therapy for locally recurrent soft tissue sarcoma: a multicentric long-term outcome analysis. Int J Radiat Oncol Biol Phys. 2014;88:143–50.PubMedCrossRef
Metadaten
Titel
Intraoperative radiotherapy-containing multidisciplinary management of trunk-wall soft-tissue sarcomas
verfasst von
C. V. Sole
F. A. Calvo
M. Cambeiro
A. Polo
A. Montero
R. Hernanz
C. Gonzalez
M. Cuervo
D. Perez
M. S. Julian
R. Martinez-Monge
Publikationsdatum
01.09.2014
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 9/2014
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-014-1157-y

Weitere Artikel der Ausgabe 9/2014

Clinical and Translational Oncology 9/2014 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.